E. Bazin and E. Baudot, Leçons théoriques et cliniques sur les affections génériques de la peau, 1862.

M. Schiff, Photoskin Tests in Hydroa Vacciniforme, Archives of Dermatology, vol.82, p.812, 1960.

M. H. Goldgeier, Hydroa vacciniforme: diagnosis and therapy, Arch Dermatol, vol.118, pp.588-591, 1982.

G. Gupta, I. Man, and D. Kemmett, Hydroa vacciniforme: A clinical and follow-up study of 17 cases, J. Am. Acad. Dermatol, vol.42, pp.208-213, 2000.

K. Iwatsuki, Pathogenic link between hydroa vacciniforme and Epstein-Barr virusassociated hematologic disorders, Arch Dermatol, vol.142, pp.587-595, 2006.

T. Oono, Coexistence of Hydroa Vacciniforme and Malignant Lymphoma, Archives of Dermatology, vol.122, p.1306, 1986.

K. Iwatsuki, Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders, Archives of Dermatology, vol.133, pp.1081-1086, 1997.

K. H. Cho, An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face, British Journal of Dermatology, vol.134, pp.791-796, 1996.

H. Asada, Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration, J. Am. Acad. Dermatol, vol.31, pp.251-255, 1994.

R. Ruiz-maldonado, Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential, J. Am. Acad. Dermatol, vol.32, pp.37-44, 1995.

M. Magaña, Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma, J. Am. Acad. Dermatol, vol.38, pp.574-579, 1998.

K. Iwatsuki, The association of latent Epstein-Barr virus infection with hydroa vacciniforme, Br. J. Dermatol, vol.140, pp.715-721, 1999.

, WHO classification of tumours of haematopoietic and lymphoid tissues: ... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), 2007.

S. Park, D. Lee, W. S. Kim, and Y. Ko, Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course, Am J Dermatopathol, vol.32, pp.832-836, 2010.

K. K. Yu, L. Franzblau, D. R. Fullen, S. A. Carty, and T. Tejasvi, Adult-onset hydroa vacciniformelike lymphoma in a long-term resident of the United States, JAAD Case Reports, vol.4, pp.314-317, 2018.

Q. Chen, S. Li, W. Li, and J. Shi, Hydroa vacciniforme-like cutaneous T-cell lymphoma, Indian Journal of Dermatology, vol.59, p.91, 2014.

Y. Li, X. Chen, X. Tian, B. Li, and Z. Li, Primary cutaneous hydroa vacciniforme-like lymphoma with indolent clinical course: report of two cases and review of literature, Int. J. Surg. Pathol, vol.21, pp.161-168, 2013.

, WHO classification of tumours of haematopoietic and lymphoid tissues. (International Agency for Research on Cancer, 2017.

M. A. Epstein, B. G. Achong, Y. M. Barr, . Virus, . In et al., Lancet, vol.1, pp.702-703, 1964.

C. M. Zmasek, D. M. Knipe, P. E. Pellett, and R. H. Scheuermann, Classification of human Herpesviridae proteins using Domain-architecture Aware Inference of Orthologs (DAIO), Virology, vol.529, pp.29-42, 2019.

O. A. Odumade, K. A. Hogquist, and H. H. Balfour, Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections, Clinical Microbiology Reviews, vol.24, pp.193-209, 2011.

Q. Y. Yao, A. B. Rickinson, and M. A. Epstein, A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals, Int. J. Cancer, vol.35, pp.35-42, 1985.

H. Williams and D. H. Crawford, Epstein-Barr virus: the impact of scientific advances on clinical practice, Blood, vol.107, pp.862-869, 2006.

J. I. Cohen, Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States, Blood, vol.117, pp.5835-5849, 2011.

J. I. Cohen, H. Kimura, S. Nakamura, Y. Ko, and E. S. Jaffe, Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, Ann. Oncol, vol.20, pp.1472-1482, 2008.

J. I. Cohen, Epstein-Barr virus infection, N. Engl. J. Med, vol.343, pp.481-492, 2000.

G. Niedobitek, The Epstein-Barr virus: a group 1 carcinogen? Virchows Arch, vol.435, pp.79-86, 1999.

S. A. Rezk, X. Zhao, and L. M. Weiss, Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update, Human Pathology, vol.79, pp.18-41, 2018.

G. Henle, W. Henle, and V. Diehl, Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A, vol.59, pp.94-101, 1968.

J. C. Niederman, R. W. Mccollum, G. Henle, and W. Henle, Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies, JAMA, vol.203, pp.205-209, 1968.

J. Stahl, P. Pavese, and J. Brion, Infections aiguës graves à virus Epstein-Barr, Réanimation, vol.14, pp.245-247, 2005.

L. S. Young and A. B. Rickinson, Epstein-Barr virus: 40 years on, Nature Reviews Cancer, vol.4, pp.757-768, 2004.

D. E. De-oliveira, G. Ballon, and E. Cesarman, NF-?B signaling modulation by EBV and KSHV, Trends in Microbiology, vol.18, pp.248-257, 2010.

J. Chen, Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications, World J Virol, vol.1, pp.154-161, 2012.

L. M. Weiss, Y. Chen, and . Eber, Situ Hybridization for Epstein-Barr Virus. in Hematological Malignancies, vol.999, pp.223-230, 2013.

R. Kerroucha, Adenocarcinomas of the stomach and distal esophagus. Incidence and phenotypic characteristics of EBV-associated cases in the Lyons area

, Ann Pathol, vol.24, pp.228-235, 2004.

A. F. Lauritzen, U. Hørding, and H. W. Nielsen, Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study, APMIS, vol.102, pp.495-500, 1994.

P. Kanavaros and P. Gaulard, Virus epstein-barr et lymphomes T/NK : intérêt physiopathologique et pratique. Revue Française des Laboratoires, pp.65-72, 2001.

J. L. Ryan, Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments, The Journal of Molecular Diagnostics, vol.6, pp.378-385, 2004.

S. Imai, Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections, J. Med. Virol, vol.40, pp.278-284, 1993.

S. D. Hudnall, T. Chen, P. Allison, S. K. Tyring, and A. Heath, Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction, Transfusion, vol.48, pp.1180-1187, 2008.

C. Amiel, Le virus Epstein-Barr (EBV) physiopathogenèse et diagnostic, pp.47-55, 2013.

Y. Hoshino, Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation, Br. J. Haematol, vol.115, pp.105-111, 2001.

K. Iwatsuki, A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections, Acta Med. Okayama, vol.58, pp.169-180, 2004.

H. Kimura, Clinical and virologic characteristics of chronic active Epstein-Barr virus infection, Blood, vol.98, pp.280-286, 2001.

M. Fujieda, H. Wakiguchi, H. Hisakawa, H. Kubota, and T. Kurashige, Defective activity of EpsteinBarr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents, Acta Paediatr Jpn, vol.35, pp.394-399, 1993.

N. Sugaya, Quantitative Analysis of Epstein-Barr Virus (EBV)-Specific CD8

+. , Cells in Patients with Chronic Active EBV Infection. The Journal of Infectious Diseases, vol.190, pp.985-988, 2004.

J. Joncas, Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection, J. Med. Virol, vol.28, pp.110-117, 1989.

H. Kimura, EBV-associated T/NK-cell lymphoproliferative diseases in nonimmuno compromised hosts: prospective analysis of 108 cases, Blood, vol.119, pp.673-686, 2012.

M. Okano, Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection, Am. J. Hematol, vol.80, pp.64-69, 2005.

U. Sundram, Cutaneous Lymphoproliferative Disorders: What's New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms, Advances In Anatomic Pathology, vol.1, 2018.

K. Kawamoto, A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features, Haematologica, vol.103, pp.1018-1028, 2018.

H. Kimura, Prognostic Factors for Chronic Active Epstein-Barr Virus Infection, The Journal of Infectious Diseases, vol.187, pp.527-533, 2003.

L. Verneuil, Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up, Br. J. Dermatol, vol.163, pp.174-182, 2010.

M. Averbeck, In situ profiling and quantification of cytokines released during ultraviolet Binduced inflammation by combining dermal microdialysis and protein microarrays, Exp. Dermatol, vol.15, pp.447-454, 2006.

, ID: gnd/1007857-5. WHO classification of skin tumours. (International Agency for Research on Cancer, 2018.

L. Quintanilla-martinez, Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma, Blood, vol.122, pp.3101-3110, 2013.

C. Chen, K. Chang, L. J. Medeiros, J. Y. Lee, and .. , Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation, J. Cutan. Pathol, vol.43, pp.1102-1111, 2016.

W. S. Kim, U. C. Yeo, H. S. Chun, and E. S. Lee, A case of hydroa vacciniforme with unusual ear mutilation, Clin. Exp. Dermatol, vol.23, pp.70-72, 1998.

P. D. Yesudian and G. R. Sharpe, Hydroa vacciniforme with oral mucosal involvement, Pediatr Dermatol, vol.21, pp.555-557, 2004.

A. Pahlow-mose, N. Fisker, O. Clemmensen, and A. Bygum, Antiviral treatment of a boy with EBVassociated hydroa vacciniforme, Case Reports, pp.2014206488-2014206488, 2014.

M. A. Levoska, Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-yearold man, Journal of the American Academy of Dermatology, vol.78, pp.637-642, 2018.

T. Miyake, Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites, Br. J. Dermatol, vol.172, pp.56-63, 2015.

D. Weedon, W. James, and . Patterson, Weedon's skin pathology, 2015.

S. N. Wong, S. H. Tan, and S. W. Khoo, Late-onset hydroa vacciniforme: two case reports, Br. J. Dermatol, vol.144, pp.874-877, 2001.

B. Demarez, Une forme sévère d'hydroa vacciniforme mimant un lupus cutanéo-articulaire, Annales de Dermatologie et de Vénéréologie, vol.145, pp.280-281, 2018.

A. Sangwan, K. Aggarwal, S. Kaur, and V. Jain, Adult-onset hydroa vacciniforme: A rare occurrence or a lymphoma premonition, Indian Dermatology Online Journal, vol.8, p.490, 2017.

J. H. Paik, Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications, Leukemia & Lymphoma, vol.58, pp.53-63, 2017.

H. Lin, Hydroa vacciniforme-like lymphoma : a case report and litterature review, 2010.

J. Li, Y. Zan, H. Liu, H. Liu, and L. Chen, Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report, Medicine, vol.97, p.319, 2018.

S. M. Rodríguez-pinilla, EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults, Am. J. Surg. Pathol, vol.34, pp.1773-1782, 2010.

Z. Xu and S. Lian, Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children, Pediatr Dermatol, vol.27, pp.463-469, 2010.

W. Au, Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients, Blood, vol.104, pp.243-249, 2004.

M. Magaña, C. Massone, P. Magaña, and L. Cerroni, Clinicopathologic Features of Hydroa Vacciniforme-Like Lymphoma: A Series of 9 Patients, Am J Dermatopathol, vol.38, pp.20-25, 2016.

J. Lysell, Antiviral Therapy in Children with Hydroa Vacciniforme, Acta Dermato Venereologica, vol.89, pp.393-397, 2009.

T. S. Sonnex and J. L. Hawk, Hydroa vacciniforme: a review of ten cases, Br. J. Dermatol, vol.118, pp.101-108, 1988.

T. Wada, Characterization of skin blister fluids from children with Epstein-Barr virusassociated lymphoproliferative disease, The Journal of Dermatology, vol.45, pp.444-449, 2018.

K. Cho, Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases, Br. J. Dermatol, vol.151, pp.372-380, 2004.

M. Sangueza and J. A. Plaza, Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases, J. Am. Acad. Dermatol, vol.69, pp.112-119, 2013.

C. Barrionuevo, Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru, Appl. Immunohistochem. Mol. Morphol, vol.10, pp.7-14, 2002.

J. A. Plaza and M. Sangueza, Hydroa Vacciniforme-Like Lymphoma With Primarily Periorbital Swelling: 7 Cases of an Atypical Clinical Manifestation of this Rare Cutaneous T-Cell Lymphoma, The American Journal of Dermatopathology, vol.37, pp.20-25, 2015.

A. A. Gru and E. S. Jaffe, Cutaneous EBV-related lymphoproliferative disorders, Semin Diagn Pathol, vol.34, pp.60-75, 2017.

P. Wen, Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder, Am J Dermatopathol, vol.41, pp.7-15, 2019.

H. Nomura, A patient with elderly-onset atypical hydroa vacciniforme with an indolent clinical course, British Journal of Dermatology, vol.173, pp.801-805, 2015.

V. Long, M. W. Liang, and S. H. Tan, Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases, Int. J. Dermatol, 2018.

Y. J. Kim, Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents, Photodermatology, Photoimmunology & Photomedicine, vol.33, pp.287-290, 2017.

P. Wen and H. Liu, Hydroa Vacciniforme-Like Cutaneous T-Cell Lymphoma in an Adult Presenting With Facial Edema and Recurrent Oral Ulceration, The American Journal of Dermatopathology, vol.40, pp.227-229, 2018.

J. Qiao and H. Fang, Hydroa vacciniforme-like lymphoma, QJM, vol.109, pp.697-698, 2016.

S. Jung, K. H. Cho, M. W. Lee, and Y. C. Kim, Hydroa Vacciniforme-Like Eruption Associated with Epstein-Barr Virus Infection in an Older Adult, Annals of Dermatology, vol.27, p.789, 2015.

H. Nomura, An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with ??T-cell proliferation, The Journal of Dermatology, vol.41, pp.360-362, 2014.

T. Wang, A rare case of hydroa vacciniforme-like cutaneous T-cell lymphoma presenting mimicking herpes simplex in an adult, Am J Dermatopathol, vol.35, pp.617-618, 2013.

K. H. Cho, Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions, Clin. Exp. Dermatol, vol.26, pp.242-247, 2001.

V. Blackwell, J. M. Mcgregor, and J. L. Hawk, Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A, Clin. Exp. Dermatol, vol.23, pp.73-76, 1998.

Y. Hirai, Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virusinfected ??T cells, J. Invest. Dermatol, vol.132, pp.1401-1408, 2012.

Y. Liu, C. Ma, G. Wang, and L. Wang, Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases, J. Am. Acad. Dermatol, 2019.

C. L. Halasz, E. E. Leach, R. R. Walther, and M. B. Poh-fitzpatrick, Hydroa vacciniforme: induction of lesions with ultraviolet A, J. Am. Acad. Dermatol, vol.8, pp.171-176, 1983.

D. R. Bickers, Hydroa vacciniforme, Arch Dermatol, vol.114, pp.1193-1196, 1978.

K. Doeden, H. Molina-kirsch, E. Perez, R. Warnke, and U. Sundram, Hydroa-like lymphoma with CD56 expression, J. Cutan. Pathol, vol.35, pp.488-494, 2008.

N. Raab-traub and K. Flynn, The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation, Cell, vol.47, pp.883-889, 1986.

M. Fukayama, R. Hino, and H. Uozaki, Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma, Cancer Science, vol.99, pp.1726-1733, 2008.

P. Murray, Epstein-Barr virus in breast cancer: artefact or aetiological agent?, The Journal of Pathology, vol.209, pp.427-429, 2006.